Continuous Glucose Monitoring System in patients with Cystic Fibrosis

Continuous Glucose Monitoring System in patients with Cystic Fibrosis - CGMS in CF

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31821

Enrollment

Registered

2008-11-24

Start date

2008-10-01

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic fibrosis and diabetes

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Cystic fibrosis 2. > 18 years

Exclusion criteria

Exclusion criteria: 1. Exocrine pancreas sufficiency 2. Former Cystic fibrosis-related diabetes diagnosis 3. Organ transplants 4. Pregnancy 5. Use of medication interfering with glucose tolerance 6. Recent pulmonary exacerbation, requiring antibiotic therapy within past 4 weeks 7. Too short follow-up period of CGMS (

Design outcomes

Primary

Measure	Time frame
Glucose values during a three-day period extracted by the CGMS and the blood glucose levels of a one-day blood glucose self-monitoring.	—

Countries

Netherlands

Outcome results